Sanofi (Sanofi) French pharmaceutical companies have spent about $ 3 million in US-2 million dollars to buy a digital technology company named Translate Bio (Translate Bio) in targets to increase the capacity of 19 million anti-American Vaccines.



French Sanofi pharmaceutical competitors in Vaccines with US two other companies are Pfizer and Moderna but failed after its type of mRNA vaccines it produced in the end of 2020 and early 2021 shows too little effectiveness.
In Sanofi's news announcement, which was mentioned by the Royator, draws that Sanofi really bought a Translate Bio. Here's the purchase of all US Translate Bio companies that consider $ 38 while the total cost of all companies equals $ 3 billion.
Sanofi CEO Mr. Paul Hudson (Paul Hudson) said buying Translate Bio will help us improve the ability to research and vaccinate-19 type mRNA.
Sanofi France's pharmaceutical companies expect to compete in the 2020 supply market with two other US companies are Pfizer and Moderna but must suffer after the mRNA vaccine it produced in 2020 and early 2021 shows too little effectiveness.
Reminder since Sanofi started researching to produce first Covid-19 vaccinations in March 2020, this French company hasn't achieved even one kind of vaccination yet to be used in any country.
Recently, European pharmaceutical agency announced that it will start a procedure to examine the actual data of the efficiency of vaccination-19 produced by French Sanofi ′′ (Vidprevtyn) to be able to propose immediate effectiveness of last year 2021